000303210 001__ 303210
000303210 005__ 20250730114249.0
000303210 0247_ $$2doi$$a10.1007/s00259-025-07455-0
000303210 0247_ $$2pmid$$apmid:40717186
000303210 0247_ $$2ISSN$$a1619-7070
000303210 0247_ $$2ISSN$$a1619-7089
000303210 037__ $$aDKFZ-2025-01561
000303210 041__ $$aEnglish
000303210 082__ $$a610
000303210 1001_ $$aSweere, Vera$$b0
000303210 245__ $$aPrognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy.
000303210 260__ $$aHeidelberg [u.a.]$$bSpringer-Verl.$$c2025
000303210 3367_ $$2DRIVER$$aarticle
000303210 3367_ $$2DataCite$$aOutput Types/Journal article
000303210 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753795079_3430
000303210 3367_ $$2BibTeX$$aARTICLE
000303210 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303210 3367_ $$00$$2EndNote$$aJournal Article
000303210 500__ $$aepub
000303210 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000303210 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303210 650_7 $$2Other$$aBiochemical recurrence-free survival
000303210 650_7 $$2Other$$aMRI
000303210 650_7 $$2Other$$aPSMA PET/CT
000303210 650_7 $$2Other$$aProstate cancer
000303210 7001_ $$aSlot, Alexandra Bruins$$b1
000303210 7001_ $$aHermsen, Rick$$b2
000303210 7001_ $$aHeetman, Joris G$$b3
000303210 7001_ $$aWever, Lieke$$b4
000303210 7001_ $$aLavalaye, Jules$$b5
000303210 7001_ $$aVinken, Maarten$$b6
000303210 7001_ $$aBahler, Clinton D$$b7
000303210 7001_ $$aTann, Mark$$b8
000303210 7001_ $$0P:(DE-HGF)0$$aKesch, Claudia$$b9
000303210 7001_ $$0P:(DE-HGF)0$$aTelli, Tugce$$b10
000303210 7001_ $$0P:(DE-HGF)0$$aFendler, Wolfgang P$$b11
000303210 7001_ $$aChiu, Peter Ka-Fung$$b12
000303210 7001_ $$aZattoni, Fabio$$b13
000303210 7001_ $$aEvangelista, Laura$$b14
000303210 7001_ $$aCeci, Francesco$$b15
000303210 7001_ $$aMiszczyk, Marcin$$b16
000303210 7001_ $$aRajwa, Pawel$$b17
000303210 7001_ $$aBarletta, Francesco$$b18
000303210 7001_ $$aBriganti, Alberto$$b19
000303210 7001_ $$aMontorsi, Francesco$$b20
000303210 7001_ $$aGandaglia, Giorgio$$b21
000303210 7001_ $$avan Basten, Jean-Paul A$$b22
000303210 7001_ $$avan Melick, Harm H E$$b23
000303210 7001_ $$avan den Bergh, Roderick C N$$b24
000303210 7001_ $$aMarra, Giancarlo$$b25
000303210 7001_ $$aScheltema, Matthijs J V$$b26
000303210 7001_ $$00000-0002-0259-8750$$aSoeterik, Timo F W$$b27
000303210 7001_ $$aParty, EAU-YAU Prostate Cancer Working$$b28$$eCollaboration Author
000303210 773__ $$0PERI:(DE-600)2098375-X$$a10.1007/s00259-025-07455-0$$pnn$$tEuropean journal of nuclear medicine and molecular imaging$$vnn$$x1619-7070$$y2025
000303210 909CO $$ooai:inrepo02.dkfz.de:303210$$pVDB
000303210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000303210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000303210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000303210 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000303210 9141_ $$y2025
000303210 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-05$$wger
000303210 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-05$$wger
000303210 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J NUCL MED MOL I : 2022$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-05
000303210 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J NUCL MED MOL I : 2022$$d2024-12-05
000303210 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x0
000303210 980__ $$ajournal
000303210 980__ $$aVDB
000303210 980__ $$aI:(DE-He78)ED01-20160331
000303210 980__ $$aUNRESTRICTED